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ABSTRACT: Gymnema sylvestre, R. Br., popularly known as Meshashringi in Sanskrit and 
Sarkaraikolli in Tamil, was investigated for the control of type I (insulin dependent) diabetes in 
experimental animals.  The hypoglycaemic extract was found to bring about blood glucose 
homeostasis, by increasing serum insulin levels.  The islets of langerhans appear to be restored 
or regulated by  the herbal extract.  Increased glycoprotein, which is the major metabolic 
abnormality in diabetes mellitus and the resultant nephropathy, retinopathy and micro and 
macroangiopathy, is brought under control by the administration of the leaf extract. 
 
INTRODUCTION 
 
Sushruta (6
th  century B.C.a) and C’ araka 
(1
st  century A. D), teachers and 
documentralists of Ayurveda have 
recommended the use of the leaves of the 
‘Sala Saradi’ group for the control of 
maturity onset diabetes in addition to diet 
restriction.  Gymnema sylvestre, R. Br. is a 
plant belonging to this group and has been 
described in “Indian Medicinal Plants” 
(Blater  et al, 1930).  The medicinal 
properties of its roots and leaves have been 
described in the ‘Indian Materia Medica’ 
(Nadkarni, 1954).  Sushruta (6
th  century 
B.C.b) described this as destroyer of 
‘madhumeha’ (glycosuria) and other urinary 
disorders. 
 
The modern scientific investigations of the 
medicinal effect of the leaves of Gymnema 
sylvestre  was initiated by Mhaskar and 
Caius (1930).  They found phytol, 
myoinositol and scyllitol as components of 
the leaves of G. sylvestre. 
 
Gymnema sylvestre is a woody branched 
climber commonly found growing wild in 
unkempt forests of Central India and the 
Western ghats.  The plant is known by 
different names in different languages.  It is 
known as Periploca of the woods in English; 
Waldschilinge in German; Meshashringi and 
Sarpadarushtrika  in Sanskrit; Gurmar  in 
Hindi;  Kogilam, Shirukurinja  and 
Sarkarikkolli  in Tamil and Podapatri    in 
Telugu (Sastri, 1956). 
 
Edgeworth first noticed the sweetness 
abolishing property (Antisaccharine 
property) of G. sylvestre leaves and this was 
confirmed by Hooper (1887) who isolated 
gymnemic acid (Hooper, 1889).  Power and 
Tutin (1904) reported the presence of 
gymnemic acid,  as glucoside with anti-
saccharine property and hentriacontane in G. 
sylvestre  leaves.    Gharpurey (1926) 
discovered that the leaves of G. sylvestre Pages  183 - 194 
given to diabetics reduced urine sugar 
levels. 
In our laboratory, various aspects of glucose 
metabolism in diabetes and its control by 
Gymnema sylvestre  have been studied.   
Panneerselvan and Shanmugasundaram 
(1978) reported the hypoglycaemic activity 
of the leaf powder in normal and diabetic 
men and rabbits.  They reported that G. 
sylvestre administration is accompanied by 
15 to 30 per cent reduction in the blood 
sugar level in the fasting state and 
postprandial condition both in normal and 
moderate diabetics in humans.  The 
extraction of the hypoglycaemic component 
of the leaves (GS2) and use of it in the 
control of blood glucose levels in diabetes 
induced by alloxan was studied by 
Shanmugasundaram et al (1981). 
 
The acid precipitate of the alcoholic extract 
(GS3) was used in further investigations.   
Rajendran and Shanmugasundaram (1980) 
have shown that the intestinal uptake of 
glucose, amino acids and water increases 
during the diabetic state and this alteration is 
reversed upon GS3  administration.  The 
abnormal functional activity of the intestinal 
brush border membrane during diabetes was 
corrected upon GS3  administration 
(Rajendran, 1981). 
 
The investigations presented in this paper 
involved the use of a further product of the 
herb, GS4  in correcting the metabolic 
abnormalities observed on inducing diabetes 
by streptozotocin injection to rats. 
 
MATERIALS AND METHODS 
 
Albino rats of both sexes used for the 
experiments were obtained from the inbred 
stock derived from Wistar stock of animals 
from the King Institute of Preventive 
Medicine, Madras.  They were maintained 
on Hindustan Lever rat feed and given water 
ad  libitum.  The chemicals used in this 
investigation were obtained as follows. 
 
Standard bovine serum albumin, crystalline 
insulin from M/s. Sigma Chemicals St. 
Louis, U. S. A., acetylacetone, orcinol, 
sodium metaperiodate from Glaxo 
Chemicals (BDH), Poole,  England, p-
dimethylaminobenzaldehyde, galactose, 
glucosamine hydrochloride and sodium 
arsenite from E. Merck, Dermstadt, West 
Germany; N-acetylneuramnic acid from 
Boehringar Mannheim, West Germany and 
insulin ‘kit’ from Bhabha Atomic Research 
Centre, Bombay, India. 
 
The plant material was collected from 
Marimrakula Kandriga in Chittoor District 
of Andhra Pradesh.  The plant which is a 
climber grow well in the bushy forests on 
the hills in this area.  The leaves are air dried 
in the shade, extracted with aqueous ethanol 
(50/50, v/v) and precipitated with HCl.  The 
precipirate which showed hypoglycaemic 
activity was purified by recrystallisation 
from aqueous alcohol.  This was labeled GS4 
and used for controlling blood glucose 
levels. 
 
Induction of diabetes mellitus and the 
experimental design 
 
Adult albino rats (weighing between 150 
and 160 g) of both sexes were fasted 
overnight and streptozotocin dissolved in 0.9 
per cent NaCl at pH 4.5 was administered 
intracardially at a dosage of 55 mg/kg body 
weight.  Animals with a fasting blood sugar 
value between 150-200 mg/dl were termed 
as diabetic. 
 
 For investigation, the experimental animals 
were divided into 3 groups.  Group I had a 
single injection of saline at the beginning of 
the experiment.  A group of rats were 
injected with streptozotocin and were Pages  183 - 194 
maintained hyperglycemic for the first four 
weeks by providing food and water ad 
libitum.  At the end of four weeks the 
animals of group III were administered the 
drug GS4 at a dose of 20 mg per day per rat, 
mixed with powdered and moistened feed. 
Each rat was fed separately and continued 
with food and water ad libitum.  After 8 
weeks of treatment the drug was 
discontinued to group III animals and the 
animals of all the three groups were 
maintained a further period of 4 weeks with 
food and water ad libitum.  At the end of 16 
weeks (4 weeks after the drug was 
discontinued in group III), glucose tolerance 
test was performed and the animals of all the 
groups were sacrificed for analyses. 
 
Liver, kidney, skeletal muscle,  epididymal 
fat and intestine were removed quickly into 
ice-cold containers.  Blood was collected in 
tubes containing EDTA as anticoagulant and 
plasma was separated.  The red blood cells 
were washed with 0.9 per cent NaCl and 
mixed with an equal volume of distilled 
water to give a hemolysate. 
 
Blood sugar and serum insulin levels were 
determined in the blood collected during the 
glucose tolerance test (GTT) by the method 
of Folin and Wu (1920) and 
radiommunoassay procedure of Herbert et al 
(1965) respectively.  Glycosylated 
haemoglobin was estimated by the method 
of Wang and Yang (1982) in the 
hemolysate.  Glycosylated plasma protein 
was estimated by the method of Merelyn et 
al (1981). 
 
While extracting the lipids from tissue, the 
residual protein left out was hydrolysed for 
the carbohydrate components bound to 
protein according to the method of 
Tettamanti  et al  (1973).  The components 
analysed in the hydrolsate were hexose 
(Niebes, 1972), hexosamine (Wagner, 
1973), and sialic acid (Warren, 1959). 
 
For statistical analysis, students‘t’ test was 
performed and ‘p’ values arrived at.  The 
untreated diabetic animals were compared to 
the normal, while those under GS4 therapy 
were compared with the untreated diabetic 
rats of group II.  Pearson’s correlation 
coefficient was obtained according to the 
method of Snedecor and Cochran (1967) and 
the glycosylated protein was correlated with 
blood glucose level. 
 
RESULTS 
 
Figure I show the control of blood glucose 
by  GS4  therapy.  The glucose levels of 
diabetic rats of group II is deteriorating with 
time, both the fasting and the post prandial 
levels being higher than that observed 4 
weeks before.  The animals of group II (on 
GS4 therapy) show improvement in glucose 
tolerance at 8
th week and progressing in the 
12
th  week.  The  glucose tolerance curve 
remains the same 4 weeks after the 
withdrawal of GS4 therapy. 
 
Figure II shows the insulin levels measured 
in serum obtained from the blood collected 
during GTT.  The levels are considerably 
lowered in the diabetic animals, and the rise 
in insulin levels is poor in hyperglycaemic 
condition.  In the animals after GS4 therapy 
even after the discontinuation of the drug, 
the insulin levels in both the fasting and 
post-prandial conditions are higher 
indicating that the β-cells have regenerated. 
 
Figure III depicts the correlation between 
fasting blood glucose and glycosylated 
haemoglobin levels.  A significant positive 
correlation is found among the control, 
diabetic and drug treated animals between 
these two parameters whose coefficients of Pages  183 - 194 
correlation are 0.89, 0.99 and 0.95 
respectively in the three groups. 
 
The correlation between the fasting blood 
glucose and glycosylated plasma proteins is 
depicted in Figure IV.  As in the case of 
glycosylated haemoglobin, a significant 
positive correlation is also found between 
fasting blood glucose and glycosylated 
plasma protein in the normal and 
experimental animals. 
 
The pattern of changes in the protein bound 
carbohydrates components in the liver, 
kidney, adipose tissue skeletal muscle and 
intestine can be seen in Table I.  In the 
diabetic rat liver and kidney, protein-bound 
hexoses are increased significantly.   
Hexosamines bound to protein are also 
elevated.  Sialic acid bound to protein is 
increased in the liver while it is lowered in 
the kidney.  There is near normalization by 
GS4  of these components.  In the adipose 
tissue, while both hexose and sialic acid are 
elevated, the increase observed for sialic 
acid is more  significant.  However, 
hexosamine shows a reduction in the 
diabetic group which is reversed in the 
controlled diabetic state (Group III).   
Hexose and sialic acid register a moderate, 
but statistically significant increase in the 
diabetic skeletal muscle which is completely 
normalized by GS4 therapy.  In the intestine, 
protein-  bound sialic acid and hexosamine 
are lowered in the diabetic state, while 
hexoses are increased.  The reversal by GS4 
therapy is not fully complete. 
 
These observations indicate that GS4 
administration to diabetic animals brings 
about blood glucose homeostasis and also 
brings back the glycoconjugate components 
to near normal levels. 
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TABLE – I 
 
Protein – bound carbohydrate components in liver, kidney, adipose tissue, skeletal muscle 
and intestine of control and experimental animals at the end of 16 weeks.  Values are 
expressed as mg/g of defatted tissues and are mean ± S. D. for ‘n’ number of animals. 
 
Tissue    Group I 
(n = 6) 
Group II 
(n = 6) 
Group III 
(n = 6) 
 
Liver 
 
Hexose 
Hexosamine 
Sialic acid 
 
 
19.09 ± 2.91 
20.04  ± 2.20 
5.58  ± 0.79 
 
39.31  ± 2.70 *** 
31.02  ± 2.00 *** 
10.43  ± 1.60 *** 
 
22.00  ± 1.70 *** 
20.35  ± 2.12 *** 
5.75 ± 1. 51 ** 
 
Kidney 
 
Hexose 
Hexosamine 
Sialic acid 
 
 
44.16 ± 5.80 
21.24 ± 3.61 
9.77 ± 2.04 
 
53.49 ± 4.73 * 
33.56 ± 4.50 *** 
5.63 ± 0.81 ** 
 
42.63 ± 3.23 ** 
22.76 ± 2.52 *** 
7.19 ± 1.61 
 
Adipose tissue 
 
Hexose 
Hexosamine 
Sialic acid 
 
 
54.65 ± 6.50 
7.86 ± 1.06 
9.29 ± 0.73 
 
64.81 ± 7.20 * 
6.20 ± 0.51 * 
13.77 ± 0.57 *** 
 
 
57.32 ± 4.80 
7.41 ± 0.73 * 
11.45 ± 0.63 *** 
 
Skeletal muscle 
 
Hexose 
Hexosamine 
Sialic acid 
 
 
25.20 ± 2.70 
13.33 ± 1.13 
2.39 ± 0.25 
 
34.74 ± 2.69 *** 
8.80 ± 1.16 *** 
3.47 ± 0.25 *** 
 
23.40 ± 3.35 ** 
12.09 ± 1.37 ** 
2.49 ± 0.33 ** 
 
Intestine 
 
Hexose 
Hexosamine 
Sialic acid 
 
 
25.90 ± 2.70 
13.12 ± 0.45 
13.90 ± 1.60 
 
34.60 ± 3.20 ** 
7.84 ± 0.85 *** 
7.47 ± 0.97 *** 
 
27.30 ± 1.40 ** 
10.79 ± 1.06 ** 
10.40 ± 1.30 ** 
 
For statistical significance group II was compared with group I and group III was compared with 
group II 
 
Significant variations are indicated as : * p 0.05; ** p 0.01; *** p 0.001 
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DISCUSSION 
 
From the observations reported in Figure I it 
can be seen that the hypoglycaemic extract 
of Gymnema sylvestre, R. Br., labeled GS4 is 
able to bring back blood glucose 
homeostasis.  It is also interesting to note 
that 4 weeks after the drug was discontinued 
(from 13
th to 16
th week) the blood glucose 
levels during GTT remained at the same 
level as at the conclusion of drug therapy in 
12
th  week.  It is also noted that this 
regulation of blood glucose levels is 
associated with increase in both glucose 
levels is associated with increase in both 
fasting and post-prandial serum insulin 
levels as a response to a glucose load (Fig. 
II).  The lower serum insulin levels found in 
the diabetic animals even after a glucose 
load (post-prandial condition) is corrected 
by the drug as seen by the increase in the 
serum insulin levels of group III animals.   
GS4, therefore facilitates the insulin release 
in response to glucose load.  Thus, GS4  
makes available circulating insulin levels 
which will correct  metabolic abnormalities 
in diabetes.  Streptozotocin induced diabetes 
is a classical model of the type I or insulin 
dependent (juvenile) diabetes, in which the 
bulk of the insulin producing β-cells of the 
islets of Langerhans are destroyed.  Hence it 
is observed that the serum insulin in the 
fasting is low and that the response of the 
pancreas to increased blood glucose level is 
only marginal with the result that increase in 
serum insulin levels after glucose ingestion 
is insufficient.  However, after GS4 therapy 
both fasting and post-prandial serum insulin 
levels are elevated indicating that the 
number  of  functional  β-cells in the 
pancreatic islets of Langerhans has 
increased by therapy.  This may suggest a 
regeneration  of  β-cells.  Histopathological 
studies (Fig. Va to Vc) reveals that the islets 
of Langerhans are intact after therapy, 
confirming the earlier findings. 
 
Glycosylated haemoglobin levels (Fig. III) 
are correlated to the blood glucose levels.   
Similar correlations are observed between 
the glycosylated plasma protein levels and 
fasting blood glucose presented in Figure 
IV.  The glycosylation of both haemoglobin 
and plasma proteins are significantly greater 
in the diabetics and this is reversed by GS4 
therapy. 
 
Glycosylation of haemoglobin interferes in 
the erythrocyte function.  In diabetics, where 
a relative deficiency of 2, 3 – 
diphosphoglycerate (2, 3-DPG from 
glycolysis) may co-exist with elevated 
glycohaemoglobin levels during periods of 
changing blood glucose concentration, may 
result in decreased oxygen delivery to 
critical tissues (Standl and Kolb, 1973). 
 
Casparie and Miedema (1977) have also 
reported such changes.  Davis and Nicol 
(1980) reported that insulin treated diabetics 
with retinopathy had a raised level of 
glycosylated haemoglobin compared with 
those without this complication, but no such 
association was found in those controlled 
with oral hypoglycaemics.  Treatment of 
diabetic rats with GS4  resulted in bringing 
back the raised glycosylated haemoglobin 
levels, indicating the superiority of GS4 over 
insulin. 
 
From Table 1, it can be seen there is a 
pattern of changes in the protein-bound 
carbohydrate components.  Increased protein 
deposition of hexose and hexosamine is 
observed in the liver and kidney of diabetic 
rats.  While sialic acid content increased in 
the liver it decreased in the kidney of 
diabetic rats. After GS4 treatment the levels 
are normalized.  In the adipose tissue and 
skeletal muscle, protein-bound sialic acid Pages  183 - 194 
levels are low, and they show a mild 
increase in diabetes.  The intestinal sialic 
acid is decreased when blood glucose is 
under control as in group III.  With GS4 
administration, the changes in the levels of 
protein  –  bound carbohydrate components 
are reversed, indicating that the pathological 
changes secondary to diabetes is reversed by 
therapy. 
 
Day  et al  (1980) found a correlation 
between glycosylated serum proteins and 
blood glucose levels in diabetic rats.  In our 
study, a significant positive correlation is 
found between the blood glucose and 
glycosylated plasma protein levels which is 
reversed upon GS4 therapy which shows that 
GS4 while bringing down the glucose levels 
corrects the associated abnormalities.  Yue 
et al  (1980) found a highly significant 
correlation between the in vivo glycosylation 
of plasma proteins and haemoglobin and 
suggested that the mean glucose 
concentration is the most important 
parameter in determining the extent of 
protein glycosylation. 
 
The above observations leads to the 
understanding that the hypoglycaemic 
extract of G. sylvestre, R. Br. Brings about 
blood glucose homeostasis, which in turn 
prevents increased glycosylation of proteins, 
thus reversing the onset of changes leading 
to micro – and macroangiopathy.  Control of 
diabetes mellitus and the associated 
complications are mediated through the 
revival or regeneration  of the insulin 
producing β-cell in the islets of Langerhans. 
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LEGEND FOR FIGURES 
 
Fig.   I  Blood glucose levels during oral glucose tolerance test in control (group I),  
    uncontrolled diabetic (group II) and GS4 treated diabetic (group III) animals. 
 
 
Fig.  II  Blood glucose and serum insulin levels of control and experimental animals at the  
    end of 16 weeks. 
 
Fig.  III  Correlation between blood glucose and glycosylated haemoglobin of control and  
    experimental animals.  The coefficient of correlation, straight line equation and  
    statistical significance between the two parameters in the different groups are as  
    below: 
 
    Control (group I)    : r = 0.89,   
              y = 1.71 x – 35.48 
              p 0.001 
 
    Uncontrolled diabetic    : r = 0.99 
    (group II)        y = 2.02 x – 391. 23 
              p 0.001 
 
    GS4 treated       : r = 0.95 
    (group III)        y = 1.78 x – 67.67  
              p 0.001  
 
Fig.   IV  Correlation between blood glucose and glycosylated plasma protein of control and  
     experimental animals.  The coefficients of correlation, straight line equation and  
     statistical significance between the two parameters in the different groups are as  
     below : 
 
    Control (group I)    : r = 0.99,   
              y = 0.029 x – 1.769 
              p 0.001 
 
    Uncontrolled diabetic    : r = 0.97 
    (group II)        y = 0.055 x – 16. 24 
              p 0.001 
 
    GS4 treated       : r = 0.27 
    (group III)        y = 0.011 x – 0.155  
              NS 
 
    NS – Not significant  
 